Pagibaximab Chimeric Monoclonal Antibody
Pagibaximabis a research-grade recombinant antibody targeting Staphylococcus Epidermidis Lipoteichoic Acid. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Staphylococcus Epidermidis Lipoteichoic Acid
Reactivity
All
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant H. pylori Glutamate--tRNA ligase 1 Protein, His-SUMO, E.coli-10ug
Recombinant Phaeosphaeria nodorum Amino-acid acetyltransferase, mitochondrial (ARG2), partial